B3P.F BIOPHARMA CREDIT DL -01

Financial Services Asset Management Frankfurt Exchange
- EUR
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
2.06%
Fundamental score
-

Is B3P.F undervalued?

Graham number

The Graham number of BIOPHARMA CREDIT DL -01 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BIOPHARMA CREDIT DL -01 fundamental analysis

No fundamental analysis for BIOPHARMA CREDIT DL -01 yet.

BIOPHARMA CREDIT DL -01 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BIOPHARMA CREDIT DL -01

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Full company profile